Navigation Links
PharmaPoint: Type 2 Diabetes - UK Drug Forecast and Market Analysis to 2022
Date:12/10/2013

London (PRWEB) December 10, 2013

PharmaPoint: Type 2 Diabetes - UK Drug Forecast and Market Analysis to 2022

Summary

GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - UK Drug Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, more than doubling over this period. The main drivers of growth will be the dramatic increase in disease prevalence and physicians’ efforts to delay disease progression and reduce the costly burden of diabetic complications through the use of combination therapies and novel branded drugs. In the emerging markets in particular, uptake of branded drugs will increase due to rapid economic growth. We anticipate that the type 2 diabetes market will not experience a fundamental shift in the classes of drugs that are preferred by physicians. Rapid uptake of drugs from the novel class of SGLT-2 inhibitors will occur; however, DPP-4 inhibitors and GLP-1 receptor agonists will continue dominating the noninsulin type 2 diabetes space. GLP-1 receptor agonists will experience the fastest growth of all classes (CAGR of 17%), due to their weight-loss effects and their novel once-weekly administration, which is preferable to the standard once- or twice-daily therapies.

A dip in sales caused by Actos patent expiry in 2012 and three insulin products’ patent expiry by 2015 will be offset by 16 pipeline product launches over the forecast period. Byetta’s patent expiration in 2016 will not have a major impact on the market as its sales have been constantly declining, with Victoza and Bydureon overtaking its shares.

Scope

-Overview of type 2 diabetes including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Pioneer in Therapeutic Patient Education, Professor Jean-Philippe Assal, Wins 2013 IDF Europe Prize in Diabetes for Long-Standing Achievement
2. Researcher studying biological factors of blood glucose variability wins 2013 IDF Europe Prize in Diabetes for Young Researcher
3. Best Practices in Patient Recruitment and Retention for Diabetes Trials, New Life Science Webinar Hosted by Xtalks
4. Enteroviruses Cause Type 1 Diabetes; New Studies Support Dr. Hanan Polansky’s Microcompetition Theory
5. Cardiometabolic Health Congress Faculty Deliver Expert Guidance on Novel Management Strategies for Diabetes and its Comorbidities
6. Investigational Diabetes Drug May Also Have Future As Treatment for Parkinsons Disease
7. Oramed Submits Pre-IND Package to FDA for ORMD-0901 (oral exenatide), an Oral GLP-1 Analog for the Treatment of Type 2 Diabetes
8. ImmusanT Initiates Study at Joslin Diabetes Center to Investigate Relationship Between Celiac Disease and Type 1 Diabetes
9. Islet Sciences, Inc. Technologies Featured in Five Separate Presentations at the American Diabetes Association Annual Meeting
10. Lillys Investigational GLP-1 Receptor Agonist, Dulaglutide, Showed Superior Glycemic Control Versus Comparators in Patients with Type 2 Diabetes
11. Results of new exploratory analyses assessing the incidence of hypoglycemia with linagliptin in adults with type 2 diabetes announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... 2015 Follow us on ... series of genetic tests that determine individual susceptibility ... disease, Huntington's disease, and Alzheimer's disease. Predictive diagnostics ... and interaction in diseased tissue/cells to understand and ... the response to treatment, such as in the ...
(Date:4/23/2015)... April 23, 2015  Veracyte, Inc. (NASDAQ: VCYT ) ... agreement to sell approximately $40 million of its common ... investors will purchase an aggregate of 4,907,975 shares of ... share, the closing stock price on April 22, 2015. ... investors, including Broadfin Capital, Camber Capital, Deerfield, Longwood Capital ...
(Date:4/23/2015)... PA (PRWEB) April 23, 2015 ... it is the first EMC® Enterprise Content Division ... the entire EMC Documentum® for Life Sciences ... has proven knowledge and capabilities to provide life ... purpose-built solutions. , The EMC Documentum Solution ...
(Date:4/23/2015)... , April 23, 2015  Metanome, Inc., ... announced the company has changed its name to ... Diversigen,s positioning as the single commercial source for ... to capitalize on the diverse opportunities of the ... that Diversigen accepts – including those that are ...
Breaking Biology Technology:Increasing Disease Prevalence & Focus on Preventive Healthcare Drive the Predictive Diagnostics Market, According to a New Report by Global Industry Analysts, Inc. 2Increasing Disease Prevalence & Focus on Preventive Healthcare Drive the Predictive Diagnostics Market, According to a New Report by Global Industry Analysts, Inc. 3Veracyte, Inc. Announces $40 Million Private Placement 2Veracyte, Inc. Announces $40 Million Private Placement 3Veracyte, Inc. Announces $40 Million Private Placement 4Glemser Earns Accreditation for Life Sciences Solution Suite 2Metanome Announces Corporate Name Change to Diversigen 2
... DIEGO, April 3, 2008 Anadys,Pharmaceuticals, Inc. (Nasdaq: ... CanAccord Adams Hepatitis C Conference on Wednesday, April 9, ... is being held at the St.,Regis Hotel in New ... Executive Officer of Anadys,Pharmaceuticals, Inc., will present an overview ...
... BioSpace, the world,s,leading online bioscience job board and ... Career Fair on Thursday, May 1, 2008. The event,will ... am to 4 pm., (Logo: http://www.newscom.com/cgi-bin/prnh/20080222/CLF013LOGO ... will attend the,biotech job fair to meet in person ...
... NEW YORK, April 2, 2008 With their ability ... as part of Big,Pharma,s strategy during lean times, and ... new report from a major life sciences market research,publisher. ... in all types,of pharmaceuticals. This $4.6 billion market has ...
Cached Biology Technology:Anadys Pharmaceuticals to Present at the CanAccord Adams Hepatitis C Conference 2Bioscience Career Fair in North Carolina Expected to Attract Well Qualified Job Seekers 2Excipients Help Pharma Extend Product Life, Profits 2
(Date:3/24/2015)... March 24, 2015   Crossmatch ™, a ... announced that its U.are.U ® 4500 Fingerprint ... Goorin Bros . to achieve PCI compliance for ... access to the POS terminal, protecting the retailer ... data breaches. With one-third of ...
(Date:3/23/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market, announces its biometric payment technology, the Wocket® smart ... starting March 30 th . The ... New York markets. Gino ... our new ad campaign following the recent initial shipment of ...
(Date:3/20/2015)... Mar. 19, 2015 Research and Markets ( ... Biometrics - Global Strategic Business Report" report to their ... Iris Biometrics in US$ Thousands. The report provides separate comprehensive ... Japan , Europe , ... and Latin America . Annual ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
... ATLANTA, Ga., April 9, 2012 /PRNewswire-iReach/ ... Inc., is pleased to announce that the company ... Cardiology Update (CCU), presented by the Division of ... April 13-14, 2012. The inaugural meeting will provide ...
... new study by Rice University scientists reveals that plants can use ... The study, which will be published in the April 24 issue ... when plants are touched. "From previous studies, we knew that ... know how these growth changes were activated," said Wassim Chehab, a ...
... Biotechnology Study Center of NYU School of Medicine will ... 2012, to honor three outstanding leaders in biomedical research. ... pure science in the development of pharmaceuticals and honors ... to improving care provided at the patient,s bedside. Recipients ...
Cached Biology News:FirstMark Exhibiting at the Inaugural Atlanta Clinical Cardiology Update 2A bit touchy: Plants' insect defenses activated by touch 2NYU School of Medicine presents 2012 Dart/NYU Biotechnology Achievement Awards 2NYU School of Medicine presents 2012 Dart/NYU Biotechnology Achievement Awards 3NYU School of Medicine presents 2012 Dart/NYU Biotechnology Achievement Awards 4NYU School of Medicine presents 2012 Dart/NYU Biotechnology Achievement Awards 5
Donor Goat Serum...
GeneRacer is an advanced RACE (rapid amplification of cDNA ends) technique that improves the efficiency of amplifying full-length 5' and 3' cDNA ends. With the GeneRacer Kit you can:...
... [APS 26] to Presenilin 2 Alzheimer's ... of the disease carry mutations in the ... precursor protein (APP). These disease-linked mutations result ... of amyloid-beta (main component of amyloid deposits ...
One-step, microplate or cuvet, colorimetric, linear detection range 0.9 mg/dL to 200 mg/dL. Procedure: 2 min....
Biology Products: